|
|
||||||||
The FASEB Journal, Vol 3, 65-70, Copyright © 1989 by The Federation of American Societies for Experimental Biology
RESEARCH COMMUNICATIONS |
J Sugatani, K Fujimura, M Miwa, T Mizuno, Y Sameshima and K Saito
Department of Medical Chemistry, Kansai Medical School, Osaka, Japan.
We detected platelet-activating substance in gastrointestinal areas, which was confirmed to be platelet-activating factor (PAF) on the basis of the following findings: 1) it comigrated with authentic PAF on thin- layer chromatography; 2) it did not aggregate PAF-desensitized platelets; and 3) its activity was completely antagonized by the receptor antagonists CV3988 and L-652,731. The level of PAF was determined with a bioassay method based on the release of [3H]serotonin from washed rabbit platelets. In the normal rat stomach, the level of PAF was high in the antrum (940 +/- 200 nmol PAF/mol phosphorus of original phospholipids), especially in the antral mucosa (1801 +/- 426 nmol/mol phosphorus of original phospholipids). The stomach PAF level was significantly altered by water immersion stress. Stress for a period of 1 h was associated with a decrease in the antral PAF level to 39 +/- 7% of that of untreated controls. This low PAF level persisted during stress. On the other hand, in the corpus, stress for periods of 1 and 3 h was associated with decreases in the PAF content, and further stress (7 h) resulted in restoration of the PAF level to normal. Furthermore, 7 h of stress was associated with distinct hemorrhagic lesions, which were prevented by CV3988 infused i.v. before the stress. This is the first report of an association between a decrease of the endogenous PAF level in animal tissues and tissue damage.
This article has been cited by other articles:
![]() |
K. Yasuda, T. Okumura, H. Okada, T. Nakajima, J. Aoki, H. Arai, K. Inoue, M. Nishizawa, S. Ito, and H. Kanzaki Platelet-Activating Factor Acetylhydrolase Isoforms I and II in Human Uterus. Comparisons with Pregnant Uterus and Myoma Biol Reprod, January 1, 2001; 64(1): 339 - 344. [Abstract] [Full Text] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |